Recombinant FGF23 (Burosumab Biosimilar) antibody

Catalog No. ABIN7795152

The Human Monoclonal anti-FGF23 (Burosumab Biosimilar) antibody is suitable to detect FGF23 (Burosumab Biosimilar) in samples from Human. It has been validated for FACS and in vivo.

Quick Overview for Recombinant FGF23 (Burosumab Biosimilar) antibody (ABIN7795152)

Target: FGF23 (Burosumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This FGF23 (Burosumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-FGF23 (Burosumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Burosumab Biosimilar, Human FGF23 Monoclonal Antibody

Characteristics: The anti-human FGF23 monoclonal antibody burosumab biosimilar was produced in mammalian cells.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Isotype: IgG1, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for FGF23 (Burosumab Biosimilar)

Target: FGF23 (Burosumab Biosimilar)

Alternative Name: Burosumab Biosimilar

Target Type: Biosimilar